Cor Vasa 2007, 49(7-8):272-276
Current concepts in preventive cardiology. Introduction to a series of publications on preventive cardiology
- Centrum preventivní kardiologie, II. interní klinika Univerzity Karlovy, Praha - Lékařská fakulta a Fakultní nemocnice v Plzni, Plzeň, Česká republika
The main goals of preventive cardiology are:
1. to prevent the development of the most frequent cardiovascular (CVD) and/or atherosclerotic vascular (AVD) diseases (primary prevention) and 2. to prevent their progression, recurrence of acute events and related morbidity (secondary prevention). Despite the downward trend of mortality from coronary heart disease, 50% of all acute coronary events continue to kill those affected before professional care can be provided! An epidemic of Type-2 diabetes is expected in this century, resulting in a further rise in the incidence, prevalence, and mortality from AVD. These facts pose an enormous challenge to preventive cardiology. The paper provides definitions for the risk factor, types of risks (absolute, relative, additive) and basic approaches in preventive cardiology (medical model and a population-based strategy).
As the most frequent AVDs and the most frequent metabolic disorders (metabolic syndrome, abnormal obesity, impaired glucose homeostasis, diabetes) are closely interrelated, the authors point to the issue of cardiometabolic risk and draw the readers' attention to the recent European guidelines for diabetes, pre-diabetes a cardiovascular disease.
Keywords: Prevention; Atherosclerotic vascular disease; Risk factors; Absolute and relative risk
Published: July 1, 2007 Show citation
References
- Macmahon B, Pugh FF. Epidemiology, Principles and Methods. Boston: Tittle Brown, 1970.
- Rose G, Blackburn H. Cardiovascular Survey Methods. Ženeva: WHO, 1968.
- Rosolová H, Šimon J, Šefrna F. Impact of cardiovascular risk factors on morbidity and mortality in Czech middle-aged men: Pilsen Longitudinal Study. Cardiology 1994; 85:61-8.
Go to original source...
Go to PubMed...
- Conroy R, Pyörällä K, Fitzgerald A, et al. Prediction of 10-year risk of fatal cardiovascular disease in Europe: the SCORE Project. Eur Heart J 2003;24:997-1003.
Go to original source...
Go to PubMed...
- De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Together with members of the Task Force. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-10.
Go to original source...
Go to PubMed...
- Cífková R, Býma S, Češka R, a spol. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Vnitř Lék 2005;51:1021-36.
- Bartechi CE, Mac Kenzie TD, Schrier RW. The human costs of tobacco use. New Engl J Med 1994;330:907-12
Go to original source...
Go to PubMed...
- McKusick VA. Human Genetics. London: Prentice-Hall, INC, 1969.
- The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007;28: 88-136.
- Šimon J a spol. Epidemiologie a prevence ischemické choroby srdeční. Praha: Grada Publishing s. r. o., 2001:264.